XML 30 R20.htm IDEA: XBRL DOCUMENT v3.20.2
Net Income Per Share (Tables)
9 Months Ended
Sep. 30, 2020
Net Income Per Share  
Schedule of computation of basic and diluted net income per share

The following table shows the computation of basic and diluted net income per share for the three and nine months ended September 30, 2020 and 2019:

Three Months Ended September 30, 

Nine Months Ended September 30, 

(In thousands except per share data)

     

2020

     

2019

     

2020

     

2019

   

Numerator:

Net income attributable to Innoviva stockholders, basic

$

28,218

$

39,809

 

$

170,499

 

$

111,339

Add: interest expense on 2023 Notes

 

1,171

 

1,157

 

3,535

 

3,482

Net income attributable to Innoviva stockholders, diluted

$

29,389

$

40,966

 

$

174,034

 

$

114,821

Denominator:

Weighted-average shares used to compute basic net income per share attributable to Innoviva stockholders

 

101,358

 

101,191

 

101,306

 

101,134

Dilutive effect of 2023 Notes

 

12,189

 

12,189

 

12,189

 

12,189

Dilutive effect of options and awards granted under equity incentive plan and employee stock purchase plan

 

25

 

35

 

48

 

71

Weighted-average shares used to compute diluted net income per share attributable to Innoviva stockholders

 

113,572

 

113,415

 

113,543

 

113,394

Net income per share attributable to Innoviva stockholders

Basic

$

0.28

$

0.39

 

$

1.68

 

$

1.10

Diluted

$

0.26

$

0.36

 

$

1.53

 

$

1.01

Schedule of anti-dilutive securities

The following common stock equivalents were not included in the computation of diluted net income per share because their effect was anti-dilutive:

Three Months Ended September 30, 

Nine Months Ended September 30, 

(In thousands)

    

2020

    

2019

    

2020

    

2019

Outstanding options and awards granted under equity incentive plan and employee stock purchase plan

1,268

 

1,144

 

1,172

 

1,128